Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Stijn van Rompay
Age : 45
Public asset : 98,255,388 USD
Linked companies : Hyloris Pharmaceuticals SA
Summary 
Stijn van Rompay is an entrepreneur and businessperson who founded Hyloris Pharmaceuticals SA, Uteron Pharma SA and Alter Pharma Group NV and who has been at the head of 5 different companies. Presently, he occupies the position of Chief Executive Officer & Executive Director at Hyloris Pharmaceuticals SA and Managing Director & Director at EXO Biologics SA.

He is also on the board of ImCyse SA and Coalesce Product Development Ltd.

In his past career he held the position of Executive Director at Alter Pharma Group NV, Chief Financial Officer of Docpharma NV and General Manager of Uteron Pharma SA.

He received a graduate degree from the University of Antwerp.


Current positions of Stijn van Rompay 
NameTitle Since
Hyloris Pharmaceuticals SA
(Pharmaceuticals)
Chief Executive Officer & Executive Director 2021
ImCyse SA Director 2012
EXO Biologics SA Managing Director & Director 2019


Holdings of Stijn van Rompay 
NameEquities%Valuation
Hyloris Pharmaceuticals SA (HYL)
(Pharmaceuticals)
7,080,65825.3%98,255,388 USD


Stijn van Rompay: Personal Network 
Most Read News 
09/28Buffett's Berkshire Hathaway buys 5.99 million more Occidental shares
RE
09/26Unilever's soap opera: M&A, Nelson Peltz, CEO to retire
RE
09/20JPMorgan CEO Dimon to warn Congress of economic 'storm clouds' -testimony
RE
09/26Twitter to interview Elon Musk, known for combative testimony
RE
09/21Trump ally Barrack's trial on foreign agent charges moves to opening statements
RE
09/20Palihapitiya to wind down two blank-check firms as choppy markets deter valuations
RE
09/29The long, winding road to Volkswagen's Porsche IPO
RE
09/21Bloomberg to spend $85 million against U.S. plastic, petrochem buildout
RE
09/28Elon Musk seeks to narrow SEC consent decree, end pre-approval of tweets
RE
09/21Samsung Elec's Lee says SoftBank's Son expected to visit Seoul -media
RE
More news


© 2022 People and Ownership :   
Stijn van Rompay : Connections